Noxopharm Limited

Noxopharm Limitedverified

NOXOF

Price:

$0.045

Market Cap:

$27.18M

Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate cancer and other solid tumors; LuPIN with combined therapy of Veyonda and 177Lu-PSMA-617 for the treatment of late-stage prostate cancer; IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of vario...[Read more]

Industry

Biotechnology

IPO Date

2020-01-29

Stock Exchange

OTC

Ticker

NOXOF

The Enterprise Value as of November 2025 (TTM) for Noxopharm Limited (NOXOF) is 28.10M

According to Noxopharm Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 28.10M. This represents a change of 49.13% compared to the average of 18.84M of the last 4 quarters.

Noxopharm Limited (NOXOF) Historical Enterprise Value (quarterly & annually)

How has NOXOF Enterprise Value performed in the past?

The mean historical Enterprise Value of Noxopharm Limited over the last ten years is 38.77M. The current 28.10M Enterprise Value has changed 7.15% with respect to the historical average. Over the past ten years (40 quarters), NOXOF's Enterprise Value was at its highest in in the June 2021 quarter at 159.46M. The Enterprise Value was at its lowest in in the March 2016 quarter at -6177623.00.

Quarterly (TTM)
Annual

Average

38.77M

Median

23.25M

Minimum

-694590.20

Maximum

143.74M

Noxopharm Limited (NOXOF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Noxopharm Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 593.41%

Maximum Annual Enterprise Value = 143.74M

Minimum Annual Increase = -3810.09%

Minimum Annual Enterprise Value = -694590.20

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202516.72M-1.48%
202416.97M77.55%
20239.56M-77.74%
202242.94M-70.13%
2021143.74M593.41%
202020.73M-63.72%
201957.14M4.30%
201854.79M112.61%
201725.77M-3810.09%

Noxopharm Limited (NOXOF) Average Enterprise Value

How has NOXOF Enterprise Value performed in the past?

The current Enterprise Value of Noxopharm Limited (NOXOF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.41M

5-year avg

45.98M

10-year avg

38.77M

Noxopharm Limited (NOXOF) Enterprise Value vs. Peers

How is NOXOF’s Enterprise Value compared to its peers?

Noxopharm Limited’s Enterprise Value is greater than Rapid Dose Therapeutics Corp. (26.58M), less than Poxel S.A. (57.07M), less than Sorrento Therapeutics, Inc. (112.78M), less than Eiger BioPharmaceuticals, Inc. (28.35M), greater than Ceapro Inc. (-5906285.00), less than American Hemp Ventures, Inc. (0), greater than RAMM Pharma Corp. (6.46M), less than Nurosene Health Inc. (0), less than Simply Better Brands Corp. (74.05M), greater than Lifeist Wellness Inc. (1.30M),

Build a custom stock screener for Noxopharm Limited (NOXOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Noxopharm Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Noxopharm Limited (NOXOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Noxopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Noxopharm Limited's Enterprise Value?

What is the highest Enterprise Value for Noxopharm Limited (NOXOF)?

What is the 3-year average Enterprise Value for Noxopharm Limited (NOXOF)?

What is the 5-year average Enterprise Value for Noxopharm Limited (NOXOF)?

How does the current Enterprise Value for Noxopharm Limited (NOXOF) compare to its historical average?